CAR T cell therapy for T cell lymphoma shows promise in phase I trial
A first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.
Read MoreA first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.
Read MoreNearly 25 years after the discovery that mutations in MECP2 gene cause Rett syndrome, the first gene therapy trial for this difficult-to-treat condition is underway.
Read MoreA simple, safe dietary intervention has an effect on the gut microbiome and metabolites in these patients.
Read MoreAn ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.
Read MoreThe immune system is meant to protect the body from foreign invaders. A rare condition called immune thrombocytopenia (ITP) occurs when the body’s defense system
Read MoreIn a dark room inside Baylor College of Medicine, study participants are asked to look at a blacked out computer screen and point to a
Read MoreMore than 30 million people in the United States alone are affected by osteoarthritis (OA), a degenerative joint disease, and that number is expected to
Read MoreThere is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies of it – which leads
Read MoreToday is Diabetes Alert Day and Dr. Ashok Balasubramanyam, professor of medicine – diabetes, endocrinology and metabolism at Baylor College of Medicine, gives us a
Read More